Avicenna J Med Biotech arij002 Avicenna Journal of Medical Biotechnology 2008-2835 2008-4625 Avicenna Research Institute ajmb40489 CRISPR-Cas System: A Promising Diagnostic Tool for Covid-19 KhanbabaeiHashemAbbasiSamanehFaniMonaSoltaniSaberZandiMiladNajafimemarZahraEbrahimiSaeedeh 14 1 3 9 15 3 2021 16 6 2021

<p><span style="font-size:11pt"><span style="font-size:10.0pt">More than a year has passed since the beginning of the 2019 novel coronavirus diseases (COVID-19) pandemic which has created massive problems globally affecting all aspects of people&#39;s life. Due to the emergence of new strains of the SARS-CoV-2, pandemic risk still remains, despite the start of vaccination. Therefore, rapid diagnostic tests are essential to control infection, improve clinical care and stop the spread of the disease. Recently CRISPR-based diagnostic tools have facilitated rapid diagnostic. Here, we review the diagnostic applications of CRISPR-Cas system in COVID-19.</span></span></p>